SWOT Analysis Strength: The myocardial infarction market has witnessed considerable research and development in the past decade. Three major companies have developed novel drugs to treat myocardial infarction. Several clinical trials have proven the efficacy and safety of these new drug entities. Weakness: The treatment landscape remains dominated by generics due to patent expiries of...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian